Skip to main content
Signal8

Jackson Andrew C.

SEC insider (Form 3/4/5 filer). CIK 0001636738. Chief Financial Officer at Calidi Biotherapeutics, Inc. (CLDI). 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 17, 2026. Located in SAN DIEGO,, CA.

Companies Jackson Andrew C. has filed insider reports for

  • Calidi Biotherapeutics, Inc. (CLDI): Officer, Chief Financial Officer
Jackson Andrew C. profile photo

Jackson Andrew C.

CIK: 0001636738

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Calidi Biotherapeutics, Inc. logo
CLDI

Calidi Biotherapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Calidi Biotherapeutics, Inc. logo
    CLDI

    Calidi Biotherapeutics, Inc.

    Aug 17, 2026
    Award

    Stock Options (right to buy)

    Direct
    14K shares-
  • Calidi Biotherapeutics, Inc. logo
    CLDI

    Calidi Biotherapeutics, Inc.

    Sep 3, 2025
    Award

    Stock Options (right to buy)

    Direct
    30K shares-
  • Calidi Biotherapeutics, Inc. logo
    CLDI

    Calidi Biotherapeutics, Inc.

    Aug 21, 2025
    Purchase
    Direct
    2.5K shares at avg. $2.00$5K

1-3 of 3